Literature DB >> 27288456

Loss of Magel2 impairs the development of hypothalamic Anorexigenic circuits.

Julien Maillard1,2, Soyoung Park1, Sophie Croizier1, Charlotte Vanacker2, Joshua H Cook1, Vincent Prevot2, Maithe Tauber, Sebastien G Bouret3,2.   

Abstract

Prader-Willi syndrome (PWS) is a genetic disorder characterized by a variety of physiological and behavioral dysregulations, including hyperphagia, a condition that can lead to life-threatening obesity. Feeding behavior is a highly complex process with multiple feedback loops that involve both peripheral and central systems. The arcuate nucleus of the hypothalamus (ARH) is critical for the regulation of homeostatic processes including feeding, and this nucleus develops during neonatal life under of the influence of both environmental and genetic factors. Although much attention has focused on the metabolic and behavioral outcomes of PWS, an understanding of its effects on the development of hypothalamic circuits remains elusive. Here, we show that mice lacking Magel2, one of the genes responsible for the etiology of PWS, display an abnormal development of ARH axonal projections. Notably, the density of anorexigenic α-melanocyte-stimulating hormone axons was reduced in adult Magel2-null mice, while the density of orexigenic agouti-related peptide fibers in the mutant mice appeared identical to that in control mice. On the basis of previous findings showing a pivotal role for metabolic hormones in hypothalamic development, we also measured leptin and ghrelin levels in Magel2-null and control neonates and found that mutant mice have normal leptin and ghrelin levels. In vitro experiments show that Magel2 directly promotes axon growth. Together, these findings suggest that a loss of Magel2 leads to the disruption of hypothalamic feeding circuits, an effect that appears to be independent of the neurodevelopmental effects of leptin and ghrelin and likely involves a direct neurotrophic effect of Magel2.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27288456      PMCID: PMC5179922          DOI: 10.1093/hmg/ddw169

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  47 in total

Review 1.  The obesity epidemic: metabolic imprinting on genetically susceptible neural circuits.

Authors:  B E Levin
Journal:  Obes Res       Date:  2000-07

2.  Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice.

Authors:  Sebastien G Bouret; Shin J Draper; Richard B Simerly
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

3.  Disruption of the paternal necdin gene diminishes TrkA signaling for sensory neuron survival.

Authors:  Ken-ichiro Kuwako; Akari Hosokawa; Isao Nishimura; Taichi Uetsuki; Masashi Yamada; Shigeyuki Nada; Masato Okada; Kazuaki Yoshikawa
Journal:  J Neurosci       Date:  2005-07-27       Impact factor: 6.167

4.  The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region.

Authors:  P Jay; C Rougeulle; A Massacrier; A Moncla; M G Mattei; P Malzac; N Roëckel; S Taviaux; J L Lefranc; P Cau; P Berta; M Lalande; F Muscatelli
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

5.  The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome.

Authors:  Rolf Fronczek; Gert Jan Lammers; Rawien Balesar; Unga A Unmehopa; Dick F Swaab
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

6.  Neonatal ghrelin programs development of hypothalamic feeding circuits.

Authors:  Sophie M Steculorum; Gustav Collden; Berengere Coupe; Sophie Croizier; Sarah Lockie; Zane B Andrews; Florian Jarosch; Sven Klussmann; Sebastien G Bouret
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

7.  Prader-Willi syndrome transcripts are expressed in phenotypically significant regions of the developing mouse brain.

Authors:  Syann Lee; Christine L Walker; Rachel Wevrick
Journal:  Gene Expr Patterns       Date:  2003-10       Impact factor: 1.224

8.  snoTARGET shows that human orphan snoRNA targets locate close to alternative splice junctions.

Authors:  Peter S Bazeley; Valery Shepelev; Zohreh Talebizadeh; Merlin G Butler; Larisa Fedorova; Vadim Filatov; Alexei Fedorov
Journal:  Gene       Date:  2007-11-21       Impact factor: 3.688

Review 9.  Mouse models of Prader-Willi Syndrome: a systematic review.

Authors:  Sandrina Bervini; Herbert Herzog
Journal:  Front Neuroendocrinol       Date:  2013-02-04       Impact factor: 8.606

Review 10.  Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity.

Authors:  Sebastien Bouret; Barry E Levin; Susan E Ozanne
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

View more
  14 in total

Review 1.  Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2.

Authors:  Klementina Fon Tacer; Patrick Ryan Potts
Journal:  Biochem J       Date:  2017-06-16       Impact factor: 3.857

2.  Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model.

Authors:  Amélie M Borie; Yann Dromard; Gilles Guillon; Aleksandra Olma; Maurice Manning; Françoise Muscatelli; Michel G Desarménien; Freddy Jeanneteau
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 3.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

4.  The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways.

Authors:  Tishani Methsala Wijesuriya; Leentje De Ceuninck; Delphine Masschaele; Matthea R Sanderson; Karin Vanessa Carias; Jan Tavernier; Rachel Wevrick
Journal:  Hum Mol Genet       Date:  2017-11-01       Impact factor: 6.150

5.  Generation of hypothalamic arcuate organoids from human induced pluripotent stem cells.

Authors:  Wei-Kai Huang; Samuel Zheng Hao Wong; Sarshan R Pather; Phuong T T Nguyen; Feng Zhang; Daniel Y Zhang; Zhijian Zhang; Lu Lu; Wanqi Fang; Luyun Chen; Analiese Fernandes; Yijing Su; Hongjun Song; Guo-Li Ming
Journal:  Cell Stem Cell       Date:  2021-05-06       Impact factor: 25.269

6.  Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome.

Authors:  Ibrahim Knani; Brian J Earley; Shiran Udi; Alina Nemirovski; Rivka Hadar; Asaad Gammal; Resat Cinar; Harry J Hirsch; Yehuda Pollak; Itai Gross; Talia Eldar-Geva; Daniela P Reyes-Capo; Joan C Han; Andrea M Haqq; Varda Gross-Tsur; Rachel Wevrick; Joseph Tam
Journal:  Mol Metab       Date:  2016-10-22       Impact factor: 7.422

Review 7.  What can we learn from PWS and SNORD116 genes about the pathophysiology of addictive disorders?

Authors:  Juliette Salles; Emmanuelle Lacassagne; Sanaa Eddiry; Nicolas Franchitto; Jean-Pierre Salles; Maithé Tauber
Journal:  Mol Psychiatry       Date:  2020-10-20       Impact factor: 15.992

Review 8.  Phenotypic spectrum and genetic analysis in the fatal cases of Schaaf-Yang syndrome: Two case reports and literature review.

Authors:  Xuefei Chen; Xiaolu Ma; Chaochun Zou
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

9.  Hypothalamic POMC deficiency increases circulating adiponectin despite obesity.

Authors:  Hui Yu; Kavaljit H Chhabra; Zoe Thompson; Graham L Jones; Sylee Kiran; Gary Shangguan; Malcolm J Low
Journal:  Mol Metab       Date:  2020-02-07       Impact factor: 7.422

Review 10.  Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.

Authors:  Felipe Correa-da-Silva; Eric Fliers; Dick F Swaab; Chun-Xia Yi
Journal:  J Neuroendocrinol       Date:  2021-06-22       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.